
Pasirinkite etiketę
rodoma tiesiai ant flakonoSR9009
SARMs
- Siunčiame iš Vokietijos
Užsakymas
- DHL su sekimu
- Diskreti pakuotė
Trumpai
SR9009 skaičiais
Pagrindiniai rodikliai iš mūsų žinyno.
Visas žinyno įrašas- Class
- Rev-erb agonistnot a SARM
- Half-life
- short
- Use
- Oralin mg, several times daily
- Sizes
- 10 mg1 size in the shop
What studies show
The source in the lexicon- Woldt et al., Nature Medicine, 2013
Produktui SR9009 laboratorinės analizės dar nėra. Balsuoti už taiUžsakykite tyrimą, mes apmokame pusęVisos laboratorinės analizės
Žinios
Viskas apie SR9009
Išsami informacija netrukus.
Are there studies in humans?
No. As of 26 October 2026 ClinicalTrials.gov lists no trial with SR9009. ChEMBL lists it without a clinical phase. All data come from cell assays and mouse models.
What does SR9009 do?
It activates REV-ERBα and REV-ERBβ, two nuclear receptors of the internal clock. They repress genes, including for fat and cholesterol production. In mice even a single dose changed the daily rhythm of activity and clock genes.
What did the endurance study show?
Muscles without REV-ERBα had fewer mitochondria and worse endurance. Mice injected with SR9009 ran longer and further in the endurance test than the comparison group. The text of the study gives no percentage for this, it is only shown as a chart.
What happened in obese mice?
After 30 days with two injections a day they lost 60 percent more weight than the comparison group and had less fat mass, without eating less. Total cholesterol fell by 47 percent, blood sugar by 19 and triglycerides by 12 percent.
Does SR9009 act only via REV-ERB?
Apparently not. A research group removed REV-ERBα and REV-ERBβ completely from liver and stem cells. SR9009 still reduced cell survival there, changed metabolism and gene reading. According to the authors SR9009 is therefore not a pure stand-in for REV-ERB.
Does it work as a tablet too?
That has not been studied. In the endurance and the obesity study SR9009 was injected into the abdominal cavity. There are no data on oral absorption in humans.
Which side effects are known?
There are no solid data because SR9009 has never been tested in humans. The mouse studies measured effects, not systematic side effects.
Susiję
Susiję produktai
MK-677 (Ibutamoren)
SARMs ir riebalų degintojai · SARMs SARMs
1 dydis
LGD-4033 (Ligandrol)
SARMs ir riebalų degintojai · SARMs SARMs
1 dydis
RAD-140 (Testolone)
SARMs ir riebalų degintojai · SARMs SARMs
1 dydis
Ostarine (MK-2866)
SARMs ir riebalų degintojai · SARMs SARMs
1 dydis
SR9009